AdaptHealth - AHCO Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AHCO shares.
View AHCO analyst ratings or view top-rated stocks.

5 equities research analysts have issued 1 year target prices for AdaptHealth's stock. Their AHCO share price forecasts range from $26.00 to $30.00. On average, they anticipate the company's share price to reach $27.67 in the next year. This suggests a possible upside of 29.7% from the stock's current price.
View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts.

AdaptHealth's stock was trading at $19.22 on January 1st, 2023. Since then, AHCO shares have increased by 11.0% and is now trading at $21.33.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our AHCO earnings forecast.

AdaptHealth Corp. (NASDAQ:AHCO) released its quarterly earnings results on Tuesday, November, 8th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.31 by $0.20. The firm had revenue of $756.50 million for the quarter, compared to analysts' expectations of $738.58 million. AdaptHealth had a net margin of 3.28% and a trailing twelve-month return on equity of 4.38%.

AdaptHealth issued an update on its FY 2022 earnings guidance on Friday, January, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.98 billion-$2.98 billion, compared to the consensus revenue estimate of $2.98 billion.

Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS).

AdaptHealth trades on the NASDAQ under the ticker symbol "AHCO."

AdaptHealth's stock is owned by a variety of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (2.21%), Reinhart Partners Inc. (0.37%), LGT Capital Partners LTD. (0.32%), Scout Investments Inc. (0.31%), New York State Common Retirement Fund (0.27%) and New York State Teachers Retirement System (0.06%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Capital Fund Ii, LP and Stephen P Griggs.
View institutional ownership trends.

Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AHCO stock can currently be purchased for approximately $21.33.

AdaptHealth (NASDAQ:AHCO) has a market capitalization of $2.87 billion and generates $2.45 billion in revenue each year. The company earns $156.18 million in net income (profit) each year or $0.43 on an earnings per share basis.

The company employs 10,700 workers across the globe.

AdaptHealth's mailing address is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. The official website for the company is www.adapthealth.com. The company can be reached via phone at (610) 424-4515 or via email at dsullivan@equityny.com.